Akorn Cracks Open A Buy Rating With Vetr

Loading...
Loading...

The Vetr crowd upgraded their rating for Akorn, Inc. AKRX on Thursday, from 3 stars (Hold), issued 13 days ago, to 3.5 stars (Buy). Crowd sentiment for Akorn is primarily positive, with 90 percent of Vetr user rating bullish.

Akorn's share price has been on a downward trend over the week, finishing Thursday down over a dollar from last week. The pharmaceutical company has been hovering above the $20 mark since falling over 20 percent following the 2016 election.

See how crowdsourced ratings could help you time the markets.

Currently, the crowd's average target price for the stock is up at $21.95, which is well below the average analyst target price of $29.70. Less than 2 percent of Vetr users are holding AKRX in their watch lists

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechUpgradesPrice TargetCrowdsourcingAnalyst RatingsVetr
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...